Research Article
Safety and Effectiveness of Mist Antiaris, a Herbal Preparation for Treatment of Peripheral Neuropathy
Table 7
Effect of Mist Antiaris on hematological parameters after eight weeks of treatment.
| | Parameters | Treatment Group | | Control | Mist Antiaris | | 10 mg/kg | 100 mg/kg | 200 mg/kg |
| | WBC (x103 /µL) | 18.5 ± 1.09 | 18.4 ± 1.27 | 18.2 ± 1.09 | 19.1 ± 1.39 | | MPV (f L) | 7.30 ± 0.12 | 7.26 ± 0.03 | 7.03 ± 0.05 | 6.95 ± 0.04 | | RBC (x106 /µL) | 7.14 ± 0.21 | 7.41 ± 0.19 | 7.73 ± 0.12 | 7.51 ± 0.15 | | Hb (g/ d L) | 13.3 ± 0.26 | 13.1 ± 0.29 | 13.8 ± 0.12 | 13.5 ± 0.22 | | HCT (%) | 42.8 ± 0.66 | 43.1 ± 0.68 | 44.4 ± 0.53 | 43.6 ± 0.58 | | MCV (f L) | 60.0 ± 1.12 | 58.3 ±0.25 | 57.5 ± 0.28 | 58.2 ± 0.63 | | MCH (pg.) | 18.6 ± 0.50 | 17.8 ± 0.25 | 17.9 ± 0.17 | 18.0 ± 0.24 | | MCHC (g/ d L) | 31.1 ± 0.17 | 30.6 ± 0.23 | 31.1 ± 0.17 | 31.0 ± 0.14 | | PLT (x103/ µL) | 864 ± 74.8 | 911 ± 56.0 | 993 ± 51.0 | 939 ± 37.5 | | LYM % | 70.9 ± 1.63 | 70.3 ± 4.95 | 75.7 ± 1.25 | 68.5 ± 4.40 | | LYM # | 13.0 ± 0.75 | 12.8 ± 1.03 | 13.7 ± 0.76 | 12.9 ± 0.83 | | RDW (f L) | 31.1 ± 0.47 | 30.0 ±0.38 | 30.7 ± 0.44 | 31.9 ± 0.97 |
|
|
Values are Mean ± SEM, n = 6
|
